A study from the Indian Council of Medical Research has claimed that Bharat Biotech's Covaxin is effective against the UK variant of the coronavirus.
Meanwhile, Sri Lanka will purchase 2 to 3 million doses on the Oxford-AstraZeneca vaccine from Serum Institute of India in the next few days.
Tune in to the Coronavirus Essential podcast for more.